Non Small Cell Lung Cancer — Adjuvant Therapy Omission for Resected NSCLC Patients With Longitudinal Undetectable MRD
Citation(s)
Dynamic Observational Strategy for Stage IB-IIIA Non-Small Cell Lung Cancer Patients After Complete Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study